Hitzenberger G, Fitscha P, Beveridge T, Nuesch E, Pacha W
Br J Clin Pharmacol. 1982; 13(Suppl 2):217S-222S.
PMID: 7104143
PMC: 1402174.
DOI: 10.1111/j.1365-2125.1982.tb01914.x.
Dhatariya R, BLOWERS A
Br J Clin Pharmacol. 1982; 13(5):723-7.
PMID: 7082540
PMC: 1402071.
DOI: 10.1111/j.1365-2125.1982.tb01443.x.
Kantelip J, Trolese J, Cromarias P, DUCHENE-MARULLAZ P
Eur J Clin Pharmacol. 1984; 27(5):535-8.
PMID: 6542864
DOI: 10.1007/BF00556888.
McDevitt D
Drugs. 1983; 25(4):331-8.
PMID: 6133735
DOI: 10.2165/00003495-198325040-00001.
Aellig W
Br J Clin Pharmacol. 1982; 13(Suppl 2):187S-192S.
PMID: 6125169
PMC: 1402142.
DOI: 10.1111/j.1365-2125.1982.tb01909.x.
Relative potency of intravenous prinodolol and propranolol in man.
Arbab A, Hicks D, Turner P
Br J Pharmacol. 1971; 42(4):665P-666P.
PMID: 4940273
PMC: 1665771.
Comparison of propranolol and LB 46 (prinodolol) on hyperthyroid tachycardia.
Arbab A, Turner P
Postgrad Med J. 1971; 47(548):329-31.
PMID: 4931824
PMC: 2466923.
DOI: 10.1136/pgmj.47.548.329.
Pharmacokinetics of pindolol in man.
Gugler R, Herold W, DENGLER H
Eur J Clin Pharmacol. 1974; 7(1):17-24.
PMID: 4853602
DOI: 10.1007/BF00614385.
Effects on cardiac muscle of the -adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve.
Singh B, Williams E
Br J Pharmacol. 1971; 43(1):10-22.
PMID: 4400181
PMC: 1665935.
DOI: 10.1111/j.1476-5381.1971.tb07152.x.
Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.
Kofi Ekue J, Lowe D, Shanks R
Br J Pharmacol. 1970; 38(3):546-53.
PMID: 4392540
PMC: 1702574.
DOI: 10.1111/j.1476-5381.1970.tb10596.x.
Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
SHAND D
Drugs. 1974; 7(1):39-47.
PMID: 4151694
DOI: 10.2165/00003495-197407010-00003.
Beta-blockers and plasma renin activity in hypertension.
Stokes G, Weber M, Thornell I
Br Med J. 1974; 1(5897):60-2.
PMID: 4149613
PMC: 1632883.
DOI: 10.1136/bmj.1.5897.60.
The effect of AH 5158, pindolol, propranolol, D-propranolol on acute exercise tolerance in angina pectoris.
Boakes A, Prichard B
Br J Pharmacol. 1973; 47(3):673P-674P.
PMID: 4147197
PMC: 1776343.
Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
Aellig W
Br J Pharmacol. 1973; 47(3):621P-622P.
PMID: 4147193
PMC: 1776302.
Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
Boucher M, DUCHENE-MARULLAZ P, Moundanga J
Br J Pharmacol. 1986; 89(1):119-27.
PMID: 2879587
PMC: 1917037.
DOI: 10.1111/j.1476-5381.1986.tb11127.x.
Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?.
Waller D
Br J Clin Pharmacol. 1990; 30(2):157-71.
PMID: 1976342
PMC: 1368213.
DOI: 10.1111/j.1365-2125.1990.tb03760.x.
An analysis of skin prick test reactions in 656 asthmatic patients.
Hendrick D, Davies R, DSouza M, Pepys J
Thorax. 1975; 30(1):2-8.
PMID: 1168378
PMC: 470237.
DOI: 10.1136/thx.30.1.2.
Effect of pindolol on intraocular pressure.
Bonomi I, Steindler P
Br J Ophthalmol. 1975; 59(6):301-3.
PMID: 1100097
PMC: 1042625.
DOI: 10.1136/bjo.59.6.301.
beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.
Aellig W
Br J Clin Pharmacol. 1976; 3(2):251-7.
PMID: 973959
PMC: 1428873.
DOI: 10.1111/j.1365-2125.1976.tb00600.x.
Comparative effects of beta adrenergic blocking drugs.
Sowton E, Das Gupta D, Baker I
Thorax. 1975; 30(1):9-18.
PMID: 235803
PMC: 470238.
DOI: 10.1136/thx.30.1.9.